79364819 - DBV TECHNOLOGIES

Information

• Trademark
• 79364819

• Source

• Serial Number

  79364819

• Registration Number

  7390033

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  September 19, 2022
  2 years ago

• Registration Date

  May 21, 2024
  9 months ago

• Transaction Date

  January 10, 2025
  2 months ago

• Status Date

  May 21, 2024
  9 months ago

• Published for Opposition Date

  March 05, 2024
  a year ago

• Location Date

  May 21, 2024
  9 months ago

• Status Code

  700

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  MARTIN, LIEF

• Attorney Docket Number

  300.026926

  Attorney Name

  Jennifer Sheehan Anderson

  Law Office Assigned Location Code

  M30

• Owners

  • DBV TECHNOLOGIES SA

Case File Statements

• GS0411: Educational services for consumers and professionals in the field of immunotherapy, namely, organizing classes, seminars, programs, conferences, congresses, workshops in the field of immunotherapy; organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of immunotherapy; publishing periodicals, books, and guides in the field of immunotherapy; database publishing services, namely publishing of periodical journals containing printed databases in tabular form in the field of immunotherapy; providing information with respect to education in the field of immunotherapy via an online website
• GS0051: Medicated adhesive devices in the nature of epicutaneous patches enabling the cutaneous or epicutaneous administration of pharmaceutical or medicated substances in dry form for humans and animals for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases; epicutaneous patches containing powdered preparations for medical use for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases; medicated occlusion patches in the nature of epicutaneous patches enabling the absorption of powdered medicated substances through the skin for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases
• GS0441: Medical services using desensitization methods on the principle of immunotherapy; medical treatment and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of allergens, antigens using patches affixed to the patients' unbroken skin, thus avoiding the transfer of allergens into the blood; medical treatment and prevention of allergies, inflammatory, autoimmune and infectious diseases using epicutaneous methods of desensitization via immunotherapy; epicutaneous medical treatments and prevention of allergies, inflammatory, autoimmune and infectious diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to allergies with respect to desensitization to combat allergies
• DS0000: "TECHNOLOGIES"
• GS0101: Medical apparatus, instruments and devices, namely, epicutaneous patches sold without medication for the cutaneous or epicutaneous administration of medicated or cosmetic substances in dry form for humans or animals; occlusion patch dispensers for medical use; medical instruments using the electrostatic properties of biocompatible media, namely, epicutaneous patches sold without medication
• GS0421: Medical and scientific research in the field of immunotherapy, namely, developing scientific methods for epicutaneous immunotherapy, to try to treat and prevent autoimmune, infectious and inflammatory diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; scientific research in the field of allergy treatment and care; scientific research in the field of allergy treatment for the repeated application of treatments to patients' skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact and thus avoid the passage of allergens into the blood; allergenic drug discovery services; medical and scientific research services, namely, developing methods for treating allergies via contact between allergens and skin immune cells; medical and scientific research services, namely, developing methods for the treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to patients' unbroken skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact

Case File Event Statements

• 3/9/2023 - 2 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 3/17/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/21/2023 - a year ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 6/29/2023 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 7/4/2023 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/5/2023 - a year ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 8/9/2023 - a year ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 8/9/2023 - a year ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 8/29/2023 - a year ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 1/26/2024 - a year ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/24/2024 - a year ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/24/2024 - a year ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/24/2024 - a year ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/14/2024 - a year ago

  17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 2/14/2024 - a year ago

  14 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 2/14/2024 - a year ago

  15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 2/14/2024 - a year ago

  16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/4/2024 - a year ago

  18 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 3/5/2024 - a year ago

  19 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/5/2024 - a year ago

  20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/21/2024 - 9 months ago

  21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/15/2024 - 9 months ago

  23 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 7/13/2024 - 8 months ago

  24 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 8/21/2024 - 6 months ago

  25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 11/9/2024 - 4 months ago

  27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 11/9/2024 - 4 months ago

  26 - FINAL DISPOSITION PROCESSED Type: FIMP

• 11/30/2024 - 3 months ago

  28 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 5/21/2024 - 9 months ago

  22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC